Adcendo secures $75m in Series C funding for ADC development
Pharmaceutical Business Review
The financing will support Adcendo's ongoing advancement of its first-in-class and best-in-class ADC pipeline targeting cancers of high unmet medical need, including further clinical development of th
pharminent
April 15, 2026 (Last updated: April 16, 2026)
Pharmaceutical Business Review
The financing will support Adcendo’s ongoing advancement of its first-in-class and best-in-class ADC pipeline targeting cancers of high unmet medical need, including further clinical development of th